VEGFA and neoplasm: Drugs that target the monocyte/macrophage populations are CCR2 blocking antibodies or antagonists, PI3K-γ inhibitor, CXCR1/2 antagonist, CD40 agonist antibodies, etc. Drugs targeting tumor vasculature include VEGF/VEGFR inhibitors, ANG inhibitors and so on.